Efficacy and Safety of Telitacicept in IgA Nephropathy and IgA Vasculitis-Associated Nephritis in Children: A Retrospective Single-Centre Study
Telitacicept was safe in pediatric IgAN/IgAVN patients and could significantly induce renal remission through reducing proteinuria and hematuria.
Authors
- Lanqi Zhou (ORCID: https://orcid.org/0000-0002-6583-5936)
- Jianhua Zhou
- Yanxinli Han
- Yu Zhang (ORCID: https://orcid.org/0000-0003-3474-422X)
- Yang Yuan (ORCID: https://orcid.org/0000-0002-5552-4958)
- Sun Wu (ORCID: https://orcid.org/0009-0007-2453-9325)
- Fengjie Yang
Institutions
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/dddt.s565279
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00